Economic costs of expanded criteria donors in renal transplantation

James F. Whiting, Muralikrishna Golconda, Roger Smith, Susan O'Brien, M. Roy First, J. Wesley Alexander

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background. The organ shortage has increased interest in the use of 'expanded criteria' donors (ECDs). Although much has been written concerning the clinical outcomes associated with the use of such donors, little has been published concerning the financial results associated with their use. Methods. A retrospective cost identification study of recipients of kidneys from expanded criteria cadaveric donors was used. Results. Of a total of 78 cadaveric renal transplants in fiscal year 1995, there were 38 kidneys (49%) transplanted from ECDs. Graft survival at I year was not statistically different between patients who received kidneys from ECDs and those who received non-ECD kidneys (84% vs. 85%, respectively). Length of stay (P<0.05), serum creatinine at 1 year after transplantation (P<0.01), and the percentage of patients requiring hemodialysis (P<0.05) were all higher among patients who received kidneys from ECDs. Cold ischemic time was significantly longer in patients who received kidneys from ECDs (31.4±12 hr vs. 24.0±9 hr; P<0.05). The total average and median costs were $12,190 and $10,911 higher in recipients of kidneys from ECDs as compared with non-ECD controls (P<0.01). Stepwise linear regression demonstrated that length of stay was the major clinical determinant of total costs; only the use of antilymphocyte induction was otherwise significantly associated. When kidneys from ECDs were transplanted into 'high-risk' recipients (age >60 or retransplant patient), the average total costs were $15,311 more than when kidneys from ECDs were transplanted into non-high-risk patients (n=16 and 21, respectively; P<0.05) and $20,680 more than when a non-ECD, non-high-risk pairing was undertaken (n=26; P<0.05). Conclusions. Kidney transplantation with organs from ECDs is significantly more expensive than with organs from non-ECDs, even in the face of similar graft survival rates. Further study is needed to determine the cost-effectiveness of renal transplantation utilizing kidneys from ECDs vis- a-vis hemodialysis.

Original languageEnglish (US)
Pages (from-to)204-207
Number of pages4
JournalTransplantation
Volume65
Issue number2
StatePublished - Jan 27 1998
Externally publishedYes

Fingerprint

Kidney Transplantation
Economics
Tissue Donors
Costs and Cost Analysis
Kidney
Graft Survival
Cost-Benefit Analysis
Renal Dialysis
Length of Stay
Survival Rate
Transplants

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Whiting, J. F., Golconda, M., Smith, R., O'Brien, S., First, M. R., & Alexander, J. W. (1998). Economic costs of expanded criteria donors in renal transplantation. Transplantation, 65(2), 204-207.

Economic costs of expanded criteria donors in renal transplantation. / Whiting, James F.; Golconda, Muralikrishna; Smith, Roger; O'Brien, Susan; First, M. Roy; Alexander, J. Wesley.

In: Transplantation, Vol. 65, No. 2, 27.01.1998, p. 204-207.

Research output: Contribution to journalArticle

Whiting, JF, Golconda, M, Smith, R, O'Brien, S, First, MR & Alexander, JW 1998, 'Economic costs of expanded criteria donors in renal transplantation', Transplantation, vol. 65, no. 2, pp. 204-207.
Whiting JF, Golconda M, Smith R, O'Brien S, First MR, Alexander JW. Economic costs of expanded criteria donors in renal transplantation. Transplantation. 1998 Jan 27;65(2):204-207.
Whiting, James F. ; Golconda, Muralikrishna ; Smith, Roger ; O'Brien, Susan ; First, M. Roy ; Alexander, J. Wesley. / Economic costs of expanded criteria donors in renal transplantation. In: Transplantation. 1998 ; Vol. 65, No. 2. pp. 204-207.
@article{45abbc3bbbd64e95874c754bde6b54bc,
title = "Economic costs of expanded criteria donors in renal transplantation",
abstract = "Background. The organ shortage has increased interest in the use of 'expanded criteria' donors (ECDs). Although much has been written concerning the clinical outcomes associated with the use of such donors, little has been published concerning the financial results associated with their use. Methods. A retrospective cost identification study of recipients of kidneys from expanded criteria cadaveric donors was used. Results. Of a total of 78 cadaveric renal transplants in fiscal year 1995, there were 38 kidneys (49{\%}) transplanted from ECDs. Graft survival at I year was not statistically different between patients who received kidneys from ECDs and those who received non-ECD kidneys (84{\%} vs. 85{\%}, respectively). Length of stay (P<0.05), serum creatinine at 1 year after transplantation (P<0.01), and the percentage of patients requiring hemodialysis (P<0.05) were all higher among patients who received kidneys from ECDs. Cold ischemic time was significantly longer in patients who received kidneys from ECDs (31.4±12 hr vs. 24.0±9 hr; P<0.05). The total average and median costs were $12,190 and $10,911 higher in recipients of kidneys from ECDs as compared with non-ECD controls (P<0.01). Stepwise linear regression demonstrated that length of stay was the major clinical determinant of total costs; only the use of antilymphocyte induction was otherwise significantly associated. When kidneys from ECDs were transplanted into 'high-risk' recipients (age >60 or retransplant patient), the average total costs were $15,311 more than when kidneys from ECDs were transplanted into non-high-risk patients (n=16 and 21, respectively; P<0.05) and $20,680 more than when a non-ECD, non-high-risk pairing was undertaken (n=26; P<0.05). Conclusions. Kidney transplantation with organs from ECDs is significantly more expensive than with organs from non-ECDs, even in the face of similar graft survival rates. Further study is needed to determine the cost-effectiveness of renal transplantation utilizing kidneys from ECDs vis- a-vis hemodialysis.",
author = "Whiting, {James F.} and Muralikrishna Golconda and Roger Smith and Susan O'Brien and First, {M. Roy} and Alexander, {J. Wesley}",
year = "1998",
month = "1",
day = "27",
language = "English (US)",
volume = "65",
pages = "204--207",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Economic costs of expanded criteria donors in renal transplantation

AU - Whiting, James F.

AU - Golconda, Muralikrishna

AU - Smith, Roger

AU - O'Brien, Susan

AU - First, M. Roy

AU - Alexander, J. Wesley

PY - 1998/1/27

Y1 - 1998/1/27

N2 - Background. The organ shortage has increased interest in the use of 'expanded criteria' donors (ECDs). Although much has been written concerning the clinical outcomes associated with the use of such donors, little has been published concerning the financial results associated with their use. Methods. A retrospective cost identification study of recipients of kidneys from expanded criteria cadaveric donors was used. Results. Of a total of 78 cadaveric renal transplants in fiscal year 1995, there were 38 kidneys (49%) transplanted from ECDs. Graft survival at I year was not statistically different between patients who received kidneys from ECDs and those who received non-ECD kidneys (84% vs. 85%, respectively). Length of stay (P<0.05), serum creatinine at 1 year after transplantation (P<0.01), and the percentage of patients requiring hemodialysis (P<0.05) were all higher among patients who received kidneys from ECDs. Cold ischemic time was significantly longer in patients who received kidneys from ECDs (31.4±12 hr vs. 24.0±9 hr; P<0.05). The total average and median costs were $12,190 and $10,911 higher in recipients of kidneys from ECDs as compared with non-ECD controls (P<0.01). Stepwise linear regression demonstrated that length of stay was the major clinical determinant of total costs; only the use of antilymphocyte induction was otherwise significantly associated. When kidneys from ECDs were transplanted into 'high-risk' recipients (age >60 or retransplant patient), the average total costs were $15,311 more than when kidneys from ECDs were transplanted into non-high-risk patients (n=16 and 21, respectively; P<0.05) and $20,680 more than when a non-ECD, non-high-risk pairing was undertaken (n=26; P<0.05). Conclusions. Kidney transplantation with organs from ECDs is significantly more expensive than with organs from non-ECDs, even in the face of similar graft survival rates. Further study is needed to determine the cost-effectiveness of renal transplantation utilizing kidneys from ECDs vis- a-vis hemodialysis.

AB - Background. The organ shortage has increased interest in the use of 'expanded criteria' donors (ECDs). Although much has been written concerning the clinical outcomes associated with the use of such donors, little has been published concerning the financial results associated with their use. Methods. A retrospective cost identification study of recipients of kidneys from expanded criteria cadaveric donors was used. Results. Of a total of 78 cadaveric renal transplants in fiscal year 1995, there were 38 kidneys (49%) transplanted from ECDs. Graft survival at I year was not statistically different between patients who received kidneys from ECDs and those who received non-ECD kidneys (84% vs. 85%, respectively). Length of stay (P<0.05), serum creatinine at 1 year after transplantation (P<0.01), and the percentage of patients requiring hemodialysis (P<0.05) were all higher among patients who received kidneys from ECDs. Cold ischemic time was significantly longer in patients who received kidneys from ECDs (31.4±12 hr vs. 24.0±9 hr; P<0.05). The total average and median costs were $12,190 and $10,911 higher in recipients of kidneys from ECDs as compared with non-ECD controls (P<0.01). Stepwise linear regression demonstrated that length of stay was the major clinical determinant of total costs; only the use of antilymphocyte induction was otherwise significantly associated. When kidneys from ECDs were transplanted into 'high-risk' recipients (age >60 or retransplant patient), the average total costs were $15,311 more than when kidneys from ECDs were transplanted into non-high-risk patients (n=16 and 21, respectively; P<0.05) and $20,680 more than when a non-ECD, non-high-risk pairing was undertaken (n=26; P<0.05). Conclusions. Kidney transplantation with organs from ECDs is significantly more expensive than with organs from non-ECDs, even in the face of similar graft survival rates. Further study is needed to determine the cost-effectiveness of renal transplantation utilizing kidneys from ECDs vis- a-vis hemodialysis.

UR - http://www.scopus.com/inward/record.url?scp=0032570285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032570285&partnerID=8YFLogxK

M3 - Article

C2 - 9458015

AN - SCOPUS:0032570285

VL - 65

SP - 204

EP - 207

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -